Concepedia

Brenner De

BD

3

Publications

81

Citations

3

H-Index

1986

Active since

Affiliations

BASF (United States)(Current)

Brenner De is an author at BASF (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1986–1990

3

Publications

3

Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulated in liposomes in patients with advanced cancer.

Creaven Pj, Cowens Jw, Brenner De et al. · PubMed · 1990 · 46 citations

, , +15

Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro.

EN Dessypris, Brenner De, Hande Kr · PubMed · 1986 · 24 citations

, , +16

Dissociation of the verapamil-induced enhancement of doxorubicin's cytotoxicity from changes in cellular accumulation or retention of doxorubicin in pancreatic cancer cell lines.

Chang Bk, Brenner De, Robert Gutman · PubMed · 1989 · 11 citations

, , +16

Rows per page

1–3 of 3